A panel of experts discuss the treatment landscape of upper GI cancer, as well as unmet needs in GI, gastric, gastroesophageal junction, and esophageal cancers.
EP. 1: Prevalence and Characteristics of GI Cancers
Syma Iqbal, MD, provides insights pertaining to various types of upper GI cancers, as well as primary characteristics and risk factors for these diseases.
EP. 2: Evolving Treatment Landscape for Upper GI and Esophageal Cancer
Evolving treatment strategies for esophagogastric cancer are explored by Syma Iqbal, MD, including unmet needs across the treatment landscape.
EP. 3: KEYNOTE-590 Trial Impacting Treatment Landscape for ESCC and Upper GI Cancer
Syma Iqbal, MD, provides an overview of the KEYNOTE-590 trial and its impact on treatment pathways for ESCC and GI cancers.
EP. 4: Overview of CheckMate Trials 648 and 649
CheckMate trials 648 and 649 explored various chemotherapy strategies for ESCC and GI cancer treatment.
EP. 5: Aligning ESCC and GI Cancer Treatment Strategies With Current Guidelines
A medical expert discusses treating patients with ESCC and GI cancers as recommended by current FDA and NCCN guidelines.
EP. 6: Quality of Life Impacted by Treatment of ESCC and Upper GI Cancer
Syma Iqbal, MD, discusses how ESCC and GI cancer treatment pathways may have a myriad of effects on patient quality of life.
EP. 7: Optimizing Treatment Pathways for Patients with ESCC and GI Cancer
Syma Iqbal, MD, shares final insights into the ESCC and GI cancer treatment landscape, emphasizing the utilization of key diagnostic tools and innovative treatment strategies.
EP. 8: The Evolving Treatment Landscape of Upper GI and Esophageal Cancer
Laura Bobolts, PharmD, BCOP, and James M. Cleary, MD, PhD, explore the evolution of treatment for patients with upper GI and esophageal cancer, including first- and second-line treatment strategies for gastroesophageal cancer.
EP. 9: Key Cost Drivers in Treating Gastroesophageal Cancers
Laura Bobolts, PharmD, BCOP, discusses key cost drivers impacting treatments for upper GI and esophageal cancers.
EP. 10: Unmet Needs for Patients With Esophageal and Upper-GI Cancers
Key opinion leaders navigate unmet needs across the treatment landscape of gastroesophageal cancer.
EP. 11: Role of Immune Checkpoint Inhibitors in Gastroesophageal Cancer Treatment Landscape
Immune checkpoint inhibitors can play a key role in the treatment of upper-GI and esophageal cancer.
EP. 12: Decision-Making Within a Rapidly Evolving Field Where Labeling May Differ From Current Clinical Guidelines
Laura Bobolts, PharmD, BCOP, and James M. Cleary, MD, provide insights regarding gastroesophageal treatment decisions when FDA labels don’t reflect clinical practice guidelines.
EP. 13: Determining Individual Treatment Sequencing for Patients with Gastroesophageal Cancer
Dr Cleary outlines strategies to individualize care for patients diagnosed with upper GI and esophageal cancer.
EP. 14: Selecting Optimal Gastroesophageal Treatment: Chemotherapy, Immunotherapy, and Combined Therapies
James M. Cleary, MD, PhD, discusses chemotherapy and immunotherapy as appropriate individual strategies, as well as a combination therapy approach for patients with gastroesophageal cancer.
EP. 15: New Gastroesophageal Treatment Therapies Impacting Patient Quality of Life
James Cleary, MD, PhD, and Laura Bobolts, PharmD, BCOP, highlight new GI and esophageal cancer therapies and their positive impacts on their patient population.
EP. 16: Defining Appropriate Response to Gastroesophageal Cancer Treatment
Expert panelists navigate optimal treatment strategies for patients with gastroesophageal cancer.
EP. 17: Immunotherapy Considerations for Upper GI and Esophageal Cancer Treatment Pathways
Key opinion leaders emphasize the significant role of immunotherapy for patients being treated for gastroesophageal cancer.
EP. 18: Evaluating Gastroesophageal Cancer Pathway Decisions
Laura Bobolts, PharmD, BCOP, discusses GI and esophageal cancer treatment pathway decisions.
EP. 19: Cost-Effective Analyses for Upper GI and Esophageal Cancer Treatment
Laura Bobolts, PharmD, BCOP, shares her perspective surrounding cost-effective analyses surrounding GI and esophageal cancers.
EP. 20: Patient-Support Services and Programs for Patients With Gastroesophageal Cancer
In her final thoughts regarding gastroesophageal cancer, Laura Bobolts, PharmD, BCOP, overviews patient support services and programs.
2 Commerce Drive Cranbury, NJ 08512